Materiality
85.25
Source
External coverage
Decided
2026-03-31
Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases
BIIB
BiogenBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Curated Events
1
Active
Recent Headlines
0
New
Recent news sentiment
+0.1
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Curated events
Sentiment decomposition
+0.1
30-day score
Company-55%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.
Recent headlines
No supplemental ticker headlines stored yet
We are still collecting relevant articles for BIIB. Curated events highlight the most material developments impacting this ticker right now.
As of 2026-03-31 • Updated scheduledSource: News desk